Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stryker’s Wingspan clipped by study showing higher stroke risk versus drug therapy

This article was originally published in Clinica

Executive Summary

Stryker’s brain stent system Wingspan has been dealt a blow after a study found that the device, when used to treat clogged arteries in the brain, was linked with an increased risk of stroke and death compared with drug therapy alone. The findings were so emphatic that enrolment in the study was halted early because of safety concerns with Wingspan. The results were published online yesterday in the New England Journal of Medicine.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097857

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel